Introduction
Background and rationale {6a}
Objectives {7}
Primary objective
Secondary objectives
-
Compare implementation outcomes (Reach, Adoption, Acceptability, Appropriateness, Feasibility, Fidelity, and Maintenance) for mPATH™-CRC and mPATH™-CheckIn between the “high touch” and “low touch” implementation strategies in a cluster-randomized controlled trial of primary care clinics.
-
Evaluate the effectiveness of mPATH™-CRC in a nested pragmatic study by comparing the proportion who complete CRC screening within 16 weeks of their visit to the clinic between a pre-implementation cohort (8 months before implementation) and a post-implementation cohort (8 months after implementation). The proportion who have a CRC screening test ordered will also be captured. Pre- vs post-implementation changes will be compared between the “high touch” and “low touch” implementation strategies and between dose levels defined based on mPATH™-CRC usage.
-
Determine the factors that facilitate or impede the maintenance of mHealth interventions like mPATH™-CRC through in-depth qualitative interviews with clinic staff, providers, and administrators.
Exploratory objectives
-
Compare implementation cost for the mPATH™ program between the “high touch” and “low touch” implementation strategies.
-
Determine the factors that facilitate or impede the maintenance of mHealth interventions like mPATH™-CRC through clinic personnel surveys.
Trial design {8}
Methods: participants, interventions, and outcomes
Study setting {9}
Eligibility criteria {10}
-
No colonoscopy within the prior 10 years
-
No flexible sigmoidoscopy within the prior 5 years
-
No computed tomography (CT) colonography within the prior 5 years
-
No fecal deoxyribonucleic acid (DNA) testing within the prior 3 years
-
No fecal blood testing (guaiac-based test with home kit or fecal immunochemical test) within the prior 12 months
Who will take informed consent? {26a}
Additional consent provisions for collection and use of participant data and biological specimens {26b}
Interventions
Explanation for the choice of comparators {6b}
Intervention description {11a}
mPATH™-CheckIn
mPATH™-CRC
Framework for implementation
“High touch” strategy
“Low touch” strategy
Criteria for discontinuing or modifying allocated interventions {11b}
Strategies to improve adherence to interventions {11c}
Relevant concomitant care permitted or prohibited during the trial {11d}
Provisions for post-trial care {30}
Outcomes {12}
Implementation outcomes
-
mPATH™-CRC Reach (by month): The proportion of patients aged 50–74 who are eligible for CRC screening who complete mPATH™-CRC or have risk factors identified by mPATH™-CheckIn in months 1–5 following implementation
-
mPATH™-CRC Reach (by socioeconomic strata): The proportion of patients aged 50–74 who are eligible for CRC screening who complete mPATH™-CRC or have risk factors identified by mPATH™-CheckIn in months 1–6 by socioeconomic strata; this outcome will also be calculated among CheckIn users only
-
mPATH™-CRC Adoption: The mean usage of mPATH™-CRC among staff and providers over the first 6 months following implementation; usage is calculated for each staff/provider as the proportion of times mPATH™-CRC is completed out of the total times mPATH™-CRC should have been launched.
-
mPATH™-CRC Acceptability, Appropriateness, and Feasibility: Mean Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), and Feasibility of Intervention Measure (FIM) scores [68] for mPATH™-CRC as assessed on the 6-month clinic personnel survey
-
mPATH™-CRC Implementation Fidelity: The proportion of patients who use mPATH™-CRC and request a CRC screening test who have a test ordered or have the order dismissed (i.e., “self-order” feature is used as designed) in months 1–6
-
mPATH™-CRC Maintenance: The proportion of patients aged 50–74 who are eligible for CRC screening who complete mPATH™-CRC or have risk factors identified by mPATH™-CheckIn in months 7–12
-
mPATH™-CheckIn Reach: The proportion of patients aged 18 or older who complete mPATH™-CheckIn in months 1–6; this outcome will be calculated overall and within socioeconomic strata
-
mPATH™-CheckIn Adoption: The mean usage of mPATH™-CheckIn among staff and providers over the first 6 months following implementation; usage is calculated for front desk staff as the proportion of times mPATH™-CheckIn is completed out of the total times mPATH™-CheckIn should have been handed out; usage is calculated for nurses/providers as the proportion of times mPATH™-CheckIn is completed and data is transmitted to the EHR out of the total times mPATH™-CheckIn should have been handed out
-
mPATH™-CheckIn Acceptability, Appropriateness, and Feasibility: Mean AIM, IAM, and FIM scores for mPATH™-CheckIn as assessed on the 6-month clinic personnel survey
-
mPATH™-CRC Maintenance: The proportion of patients aged 18 or older who complete mPATH™-CheckIn in months 7–12
-
mPATH™ Implementation Cost: Cost to implement and maintain usage of the mPATH™ program from the perspective of a healthcare system considering implementation, including hardware (i.e., iPads, cases, charging cabinets), cloud data storage fees, training, and technical support. Clinic staff training costs will be computed using training time and national average wage values for nursing and other staff from the Bureau of Labor Statistics. Technical support costs will include travel and support staff time costs associated with the initial training, and any follow-up trainings. Ongoing costs to maintain usage of mPATH™ include costs to train new employees or replace hardware and technical support costs related to follow-up training, troubleshooting, and adapting the program as needed.
Effectiveness outcomes
Mixed methods outcomes
Participant timeline {13}
Sample size {14}
Primary outcome (mPATH™-CRC Reach)
80% power | 90% power | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Diff/ICC | .03 | .04 | .05 | .06 | .07 | .08 | .03 | .04 | .05 | .06 | .07 | .08 |
.15 | 22 | 26 | 29 | 33 | 36 | 40 | 30 | 34 | 39 | 44 | 48 | 53 |
.20 | 12 | 14 | 16 | 18 | 20 | 22 | 16 | 19 | 22 | 24 | 27 | 29 |
Effectiveness outcome
80% power | 90% power | |||||||
---|---|---|---|---|---|---|---|---|
ICC | .03 | .04 | .05 | .06 | .03 | .04 | .05 | .06 |
.087 | .100 | .113 | .125 | .102 | .118 | .133 | .146 |
80% power | ||||
---|---|---|---|---|
ICC | .03 | .04 | .05 | .06 |
2.903 | 3.462 | 4.097 | 4.819 |